Home

Fortrea Holdings Inc. - Common Stock (FTRE)

5.1200
-0.1100 (-2.10%)
NASDAQ · Last Trade: Jun 6th, 1:01 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close5.230
Open5.220
Bid4.400
Ask5.910
Day's Range5.010 - 5.335
52 Week Range3.991 - 28.41
Volume3,061,611
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume3,505,510

Chart

About Fortrea Holdings Inc. - Common Stock (FTRE)

Fortrea Holdings Inc. is a biotechnology company focused on developing and commercializing innovative therapeutics for unmet medical needs, particularly in the fields of oncology and rare diseases. The company leverages advanced scientific research and technology to create transformative treatment options that aim to improve patient outcomes and quality of life. Through a combination of cutting-edge drug development and strategic partnerships, Fortrea Holdings is dedicated to bringing new therapies to market while adhering to rigorous safety and efficacy standards in the healthcare industry. Read More

News & Press Releases

Deadline Approaching: Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming August 1, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, inclusive (the “Class Period”).
FTRE BREAKING NEWS: Fortrea Holdings Inc. Stock Plummets 25% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:FTRE)
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · June 5, 2025
Law Offices of Frank R. Cruz Encourages Fortrea Holdings Inc. (FTRE) Investors To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, inclusive (the “Class Period”). Fortrea investors have until August 1, 2025 to file a lead plaintiff motion.
Earnings Scheduled For May 12, 2025benzinga.com
Via Benzinga · May 12, 2025
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Fortrea Holdings Inc. (FTRE) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, inclusive (the “Class Period”). Fortrea investors have until August 1, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · June 4, 2025
FTRE Q1 CY2025 Earnings Call: Revenue Miss, Adjusted Profit Beat, and CEO Transition
Clinical research company Fortrea Holdings (NASDAQ:FTRE) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.6% year on year to $651.3 million. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Via StockStory · June 4, 2025
FTRE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces That Fortrea Holdings Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fortrea Holdings Inc. (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, inclusive (the “Class Period”), have until August 1, 2025 to seek appointment as lead plaintiff of the Fortrea class action lawsuit. Captioned Deslande v. Fortrea Holdings Inc., No. 25-cv-04630 (S.D.N.Y.), the Fortrea class action lawsuit charges Fortrea and certain of Fortrea’s top executives with violations of the Securities Exchange Act of 1934.
FORTREA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ:FTRE) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Fortrea securities between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”). Investors have until August 1, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · June 3, 2025
Law Offices of Howard G. Smith Encourages Fortrea Holdings Inc. (FTRE) Investors to Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, inclusive (the “Class Period”). Fortrea investors have until August 1, 2025 to file a lead plaintiff motion.
Fortrea to Present at the Jefferies Global Healthcare Conference
DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.
By Fortrea Holdings Inc · Via GlobeNewswire · June 3, 2025
FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fortrea Holdings Inc. (“Fortrea” or “the Company”) (NASDAQ: FTRE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · June 3, 2025
FORTREA HOLDINGS INC. (NASDAQ: FTRE) INVESTOR ALERT: Investors With Large Losses in Fortrea Holdings Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · June 3, 2025
Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers of Fortrea Holdings, Inc. (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”). Fortrea is a global contract research organization.
By Rosen Law Firm · Via Business Wire · June 3, 2025
3 Value Stocks in Hot Water
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Via StockStory · May 19, 2025
Beyond The Numbers: 6 Analysts Discuss Fortrea Holdings Stockbenzinga.com
Via Benzinga · May 13, 2025
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · May 12, 2025
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company’s possible violations of federal securities laws.
Why Fortrea (FTRE) Stock Is Falling Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 14.3% in the afternoon session after the company reported first quarter 2025 earnings as the news of the CEO stepping down dominated, casting a shadow over the otherwise decent results. The company announced that Lead Independent Director, Peter M. Neupert, will serve as Interim Chief Executive Officer and Board Chair, as Thomas Pike stepped down from his role beginning May 13, 2025. This likely created some uncertainty regarding the near-term direction of the business, which investors typically react negatively to. Also, sales slipped a bit compared to the previous year. Still, Fortrea blew past analysts' sales and earnings forecasts. Zooming out, we think this quarter featured some important positives marred by the uncertainty of leadership.
Via StockStory · May 12, 2025
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz continues its investigation of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Fortrea’s (NASDAQ:FTRE) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations
Clinical research company Fortrea Holdings (NASDAQ:FTRE) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $651.3 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Fortrea Reports First Quarter 2025 Results
For the three months ended March 31, 2025, from continuing operations:
By Fortrea Holdings Inc · Via GlobeNewswire · May 12, 2025
Fortrea Announces CEO Stepping Down
Peter M. Neupert, Fortrea’s Lead Independent Director, will serve as Interim CEO as Thomas Pike steps down
By Fortrea Holdings Inc · Via GlobeNewswire · May 12, 2025
Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting results tomorrow before market open. Here’s what to expect.
Via StockStory · May 11, 2025
3 Volatile Stocks Skating on Thin Ice
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.
Via StockStory · May 9, 2025
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
Recognized in both pre-and post-approval pharmacovigilance operations
By Fortrea Holdings Inc · Via GlobeNewswire · May 1, 2025